This trial will study the effects of a drug on blood sugar and insulin levels in people who have low blood sugar after weight-loss surgery.
- Post-Bariatric Hypoglycemia
5 Primary · 6 Secondary · Reporting Duration: Through study completion, 34 days
Awards & Highlights
2 Treatment Groups
Treatment Arm A
1 of 2
Treatment Arm B
1 of 2
10 Total Participants · 2 Treatment Groups
Primary Treatment: Mizagliflozin · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18 - 75 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does Mizagliflozin have the green light from the FDA?
"Mizagliflozin's safety was given a score of 2 because, although there is some data supporting its safety, none of it suggests that the drug is effective." - Anonymous Online Contributor
What are the goals that researchers hope to achieve with this clinical trial?
"The primary objective of the Vogenx clinical trial, which will be conducted over a 34-day period, is to evaluate laboratory tests. Additionally, the study will also assess secondary outcomes including time to peak insulin concentration after mizagliflozin dosing during MMTT, MMTT insulin concentrations area under the curve (AUC0-1, AUC0-2, AUC0-3, AUC0-4, and AUC0-6) after mizagliflozin dosing, and time to peak plasma glucose concentration after mizagliflozin dosing during M" - Anonymous Online Contributor
Are participants still being accepted for this clinical trial?
"Yes, this study is still looking for patients to enroll. The trial was posted on September 13th, 2020 and updated October 11th, 2020 according to the clinicaltrials.gov website." - Anonymous Online Contributor
What are the prerequisites for joining this clinical research project?
"The aim of this study is to enroll 9 individuals that suffer from hypoglycemia and meet the age criteria of being between 18-75 years old. There are additional requirements for participants which include: having had Roux-en-Y gastric bypass surgery over 6 months ago and a diagnosis of PBH." - Anonymous Online Contributor
Do octogenarians fit the profile of patients this trial is designed to help?
"This study is open to individuals who are between the ages of 18 and 75." - Anonymous Online Contributor
What is the projected sample size for this clinical trial?
"That is correct. Based on the information provided by clinicaltrials.gov, this study is looking for 9 individuals to fill 1 vacant position(s). The posting date was September 13th, 2022 with the most recent update being October 11th, 2022." - Anonymous Online Contributor